[Tumor hypoxia: a key player in the regulation of stromal and anti-tumor responses]

Med Sci (Paris). 2014 Apr;30(4):422-8. doi: 10.1051/medsci/20143004017. Epub 2014 May 5.
[Article in French]

Abstract

Hypoxia is a major feature of most solid tumors. Cells adapt to lower oxygen availability by stabilizing HIF transcription factors, which in turn activate the expression of many genes resulting in the survival and maintenance of cellular functions. In tumor cells, exposure to hypoxic stress results in the activation, via the HIF factors, of a series of genes enabling tumor cells to resist to killing by cytotoxic effectors of the immune system. Tissue hypoxia also controls the functions and differentiation of immune cells. This review describes the hypoxia-induced mechanisms of tumor resistance to killing by cytotoxic effectors, and the functional effects of hypoxia on the immune cells.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Cell Hypoxia / drug effects
  • Humans
  • Immunity, Cellular / physiology
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Tumor Microenvironment / drug effects
  • Tumor Microenvironment / physiology*